HCPCS Code Q5117: Injection, Trastuzumab-anns, Biosimilar, (Kanjinti), 10 mg

Learn about the HCPCS code Q5117 for "Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg" through this guide.

Frequently asked questions

In 10 mg increments. For example, if 500 mg was infused, bill 50 units of Q5117.

It's normal to feel pain and discomfort in the injection site. Taking this injection might make the patient nauseous, though. The more severe but rare complications that could happen include congestive heart failure, allergic reactions, and injection site infections.

Some patients will notice the benefits in a few weeks. Some might take a few months.